China signs deal to ensure COVID vaccines to developing countries

She gave no details on how much money China would commit to the deal, which has a fundraising goal of $2 billion and aims to provide 92 low and middle-income countries with a future vaccine.;

Published On 2020-10-10 04:00 GMT | Update On 2020-10-10 04:01 GMT

China: China has signed up to a deal to ensure future Covid-19 vaccines are distributed to developing countries, the biggest economy yet to join the World Health Organization-led bid to control the pandemic. The COVAX pledge to get vaccines to poorer nations as soon as they are developed aims to head off fears rich countries will limit distribution of game-changing medicines made by their pharmaceutical companies.

The deal gives China, the country where the virus first emerged, a prominent role in the global effort to share vaccines with less-developed countries. China joined COVAX to "honour its commitment to turn Covid-19 vaccines into a global public good," foreign ministry spokeswoman Hua Chunying said Friday of the October 8 agreement.

She gave no details on how much money China would commit to the deal, which has a fundraising goal of $2 billion and aims to provide 92 low and middle-income countries with a future vaccine.

Chinese vaccines "will be provided to developing countries as a priority", Hua said, adding Beijing hopes "more capable countries will also join and support COVAX". Superpower rival the US has not signed up to the deal. China is racing to find a vaccine, with Beijing making bold predictions on its rollout before the end of the year.

Hundreds of thousands of Chinese soldiers, emergency staff and overseas workers have already been injected with vaccines - although the leading contenders are yet to complete clinical trials.

Beijing is facing a storm of foreign criticism over its early handling of the pandemic and has been trying to reframe perceptions of its role in Covid-19, which emerged in the central Chinese city of Wuhan. China has paraded its success in controlling the pandemic inside its borders.

Tens of millions of people returned to work on Friday after a long "Golden Week" domestic holiday seen as a test of consumer confidence, cutting a stark contrast to many Western nations afflicted by rolling lockdowns and travel restrictions.

Article Source : AFP

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

China signs deal to ensure COVID vaccines to developing countries

She gave no details on how much money China would commit to the deal, which has a fundraising goal of $2 billion and aims to provide 92 low and middle-income countries with a future vaccine.;

Similar News

Zydus Foundation Vice Chairperson Meha Patel appointed as Member of CII National Committee on Art & Culture for 2025-26

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC

Delhi to form special committee to crush fake medicine racket

Roche Pharma teams up with 10 Govt Hospitals to power up clinical trial capacities in India

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive

Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute

Nellore Horror: 21-year-old B.Pharm student stabbed to death